Chondros Dimitrios 4
4 · HALOZYME THERAPEUTICS INC · Filed Jun 5, 2018
Insider Transaction Report
Form 4
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2018-06-01+2,043→ 36,119 total - Tax Payment
Common Stock
2018-06-01$18.59/sh−712$13,236→ 35,407 total - Exercise/Conversion
Restricted Stock Units
2018-06-01−2,043→ 6,127 totalExercise: $0.00→ Common Stock (2,043 underlying)
Footnotes (2)
- [F1]The reported disposition of 712 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
- [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.